MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization

How Taxpayer-Funded Research Led to a $2 Million Gene Therapy: The Zolgensma Story

This investigative piece traces the development of Zolgensma, a gene therapy for spinal muscular atrophy that became the world's most expens

Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.

Chemistry Ventures is raising $500M for its second fund

Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal

Framework Ventures launches $400M fund to back tokenization as financing layer for AI, robotics, and energy

Framework Ventures has launched a $400 million fund based on the thesis that blockchain technology — specifically tokenization and stablecoi

Framework Ventures launches $400M fund to back tokenization as financing layer for AI, robotics, and energy

Framework Ventures has launched a $400 million fund based on the thesis that blockchain technology — specifically tokenization and stablecoi

Biotech venture capital roundup: Osanni Bio leads with $190M Series B

A roundup of recent venture capital financings in the biotech sector, headlined by Osanni Bio's $190 million Series B round to fund drug can